Hi Teddy,
I can really only go off the same announcements everyone else can, but I would be fairly confident to say that they would have recruited the additional 25 patients as per the same criteria by which they recruited all other patients.
If this were not so, the additional patients could not be used to add additional statistical power to the primary endpoint - which we know not to be the case! :)
Hope this helps!
- Forums
- ASX - By Stock
- TSN
- questions re phase 3 trial
questions re phase 3 trial, page-7
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online